To view the clinical trial data of the following topics click here (pdf format)

Prostate cancer
Bone health in men receiving androgen deprivation therapy

Christina M. Canil, MD, FRCPC, Medical Oncologist, The Ottawa Hospital Cancer Centre, Assistant Professor, Department of Medicine, University of Ottawa, Ottawa ON

TRIAL SUMMARY: Denosumab for prevention of fractures

Non-small cell lung cancer
Treatment of advanced disease

Cheryl Ho, MD, FRCPC, Medical Oncologist, British Columbia Cancer Agency; Clinical Assistant Professor of Medicine, University of British Columbia, Vancouver, BC

STUDY SUMMARY: Gefitinib monotherapy

Molecular-based treatment

Gwyn Bebb, BMBCh, PhD, FRCPC, Medical Oncologist, Tom Baker Cancer Centre; Assistant Professor, University of Calgary, Calgary, AB

STUDY SUMMARY: Predictive value of KRAS status
in NSCLC

Breast cancer
Combining targeted therapies in women with metastatic breast cancer
Caroline Lohrisch, MD, FRCPC, Medical Oncologist, British Columbia Cancer Agency.

TRIAL SUMMARY: Lapatinib + trastuzumab in women with MBC

Prevention

Joseph Ragaz, MD, FRCPC, Clinical Professor, Medicine, School of Population & Public Health, University of British Columbia; Adjunct Professor Medicine & Oncology, McGill University, Montreal, Quebec

TRIAL SUMMARY: Oral Bisphosphonates and Breast Cancer Prevention.

Hormonal therapy in postmenopausal early breast cancer

Shailendra Verma, MD, FRCPC, FACP, Medical Oncologist, Ottawa Hospital Regional Cancer Centre; Associate Professor, Department of Medicine, University of Ottawa

TRIAL SUMMARY: Exemestane vs tamoxifen followed by exemestane

TRIAL SUMMARY: Tamoxifen followed by exemestane vs tamoxifen

To view the clinical trial data click here (pdf format)